Outlook for the next 5 years in drug innovation

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Compounds in clinical development by therapeutic area.
Figure 2: Innovative pipeline composition by therapeutic area.
Figure 3: Historic and forecasted number of launches.

References

  1. 1

    Paul, S. M. et al. How to improve R&D productivity: the pharmaceutical industry's grand challenge. Nature Rev. Drug Discov. 9, 203–215 (2010).

    CAS  Google Scholar 

  2. 2

    David, E., Tramontin, T. & Zemmel, R. Pharmaceutical R&D: the road to positive returns. Nature Rev. Drug Discov. 8, 609–610 (2009).

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Martin Møller.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary information Box S1

Data sources and analysis methodology (PDF 128 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Berggren, R., Møller, M., Moss, R. et al. Outlook for the next 5 years in drug innovation. Nat Rev Drug Discov 11, 435–436 (2012). https://doi.org/10.1038/nrd3744

Download citation

Further reading

Search

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing